EVERSION
Develops medtech for identifying and addressing shoe-related foot pain, helping users manage discomfort linked to footwear.
Overview
EVERSION is a German medtech company focused on pain and discomfort that can be hidden in footwear. Its offering targets foot-health issues associated with shoes, serving people experiencing shoe-related pain. The company’s differentiation is its focused approach to an everyday source of musculoskeletal discomfort rather than a broad healthcare platform. EVERSION has raised about €2M in an undisclosed round announced in July 2026.
Funding History
German medtech EVERSION raises €2.3M to tackle the pain hiding in your shoes
Frequently Asked Questions
- How much funding does AI Funding track for EVERSION?
- AI Funding tracks €2M for EVERSION across 1 funding round in this database.
- What does EVERSION do?
- EVERSION is a German medtech company focused on pain and discomfort that can be hidden in footwear. Its offering targets foot-health issues associated with shoes, serving people experiencing shoe-related pain. The company’s differentiation is its focused approach to an everyday source of musculoskeletal discomfort rather than a broad healthcare platform. EVERSION has raised about €2M in an undisclosed round announced in July 2026.
- Where is EVERSION headquartered?
- EVERSION is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.